Stefan A. Traussnigg
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Journal: Hepatology international
Published: January 28, 2021
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.
Journal: Wiener klinische Wochenschrift
Published: May 22, 2020
Prevalence of anti-Hepatitis E antibodies and impact on disease severity in non-alcoholic fatty liver disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 02, 2020
Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects.
Journal: The American journal of clinical nutrition
Published: April 17, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Journal: The lancet. Gastroenterology & hepatology
Published: November 08, 2018
Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 26, 2017
Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial.
Journal: Obesity surgery
Published: November 12, 2016
Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease.
Journal: Digestive diseases (Basel, Switzerland)
Published: June 23, 2016
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
Published: June 06, 2016
Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.
Journal: Obesity surgery
Published: March 19, 2016
Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Journal: Seminars in liver disease
Published: February 13, 2016
Difficult case of Cronkhite-Canada syndrome with small intestinal bacterial overgrowth, Clostridium difficile infection and polymyalgia rheumatica.
Journal: BMJ case reports
Published: January 29, 2016
Last Updated: 09/26/2026